Literature DB >> 7691674

Insulinlike growth factors and binding proteins in colon cancer.

P Singh1, N Rubin.   

Abstract

Insulinlike growth factors (IGFs) express anabolic and mitogenic activity on wide variety of cells. Besides endocrine effects, IGFs have major autocrine and paracrine effects on many cellular functions. Two factors that significantly affect the extent of cellular response to IGFs include the membrane receptors for IGFs and the soluble binding proteins (BPs), which modulate the action of IGFs at the receptor level. IGFs, IGF receptors, and IGFs and their BPs (IGF-BPs) thus constitute three components of the IGF system. A role of IGFs in the transformation and proliferation of cancer cells has become increasingly evident in the past few years. Studies from several laboratories show that all three components of the IGF system may play an important role in the proliferation of colon cancers. It was recently shown that the relative expression of IGFs and IGF/BPs may critically control the metastatic potential of colon cancers. The purpose of this article is to summarize our current knowledge of the IGF system and to present support for a significant role of IGFs in the initiation and growth of colon cancers. The expression and structural aspects of IGFs, their receptors, and BPs are outlined first, followed by a discussion of the role of IGFs in gastrointestinal functions and in colon cancers.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7691674     DOI: 10.1016/0016-5085(93)90971-e

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  17 in total

Review 1.  Cytokines and metabolic factors regulate tumoricidal T-cell function during cancer immunotherapy.

Authors:  Adam J Adler; Payal Mittal; Joseph M Ryan; Beiyan Zhou; Jeffrey S Wasser; Anthony T Vella
Journal:  Immunotherapy       Date:  2017-01       Impact factor: 4.196

2.  Expression of the insulin-like growth factors and their receptors in adenocarcinoma of the colon.

Authors:  S Freier; O Weiss; M Eran; A Flyvbjerg; R Dahan; I Nephesh; T Safra; E Shiloni; I Raz
Journal:  Gut       Date:  1999-05       Impact factor: 23.059

3.  Insulin-like growth factor-I in Helicobacter pylori gastritis and response to eradication using bismuth based triple therapy.

Authors:  A S Taha; G Beastall; R Morton; R H Park; A D Beattie
Journal:  J Clin Pathol       Date:  1996-08       Impact factor: 3.411

Review 4.  Mechanisms of obesity-induced gastrointestinal neoplasia.

Authors:  José O Alemán; Peter R Holt; Leonardo H Eusebi; Luigi Ricciardiello; Kavish Patidar; Arun J Sanyal
Journal:  Gastroenterology       Date:  2013-12-06       Impact factor: 22.682

5.  Plasma insulin-like growth factor 1, insulin-like growth factor binding protein 3, and risk of colorectal cancer: a prospective study in northern Sweden.

Authors:  R Palmqvist; G Hallmans; S Rinaldi; C Biessy; R Stenling; E Riboli; R Kaaks
Journal:  Gut       Date:  2002-05       Impact factor: 23.059

Review 6.  Influence of obesity on the risk of developing colon cancer.

Authors:  E E Frezza; M S Wachtel; M Chiriva-Internati
Journal:  Gut       Date:  2005-10-20       Impact factor: 23.059

7.  Insulin-like growth factors are more effective than progastrin in reversing proapoptotic effects of curcumin: critical role of p38MAPK.

Authors:  Pomila Singh; Shubhashish Sarkar; Shahid Umar; William Rengifo-Cam; Amar P Singh; Thomas G Wood
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-02-04       Impact factor: 4.052

Review 8.  Acromegaly: re-thinking the cancer risk.

Authors:  Siobhan Loeper; Shereen Ezzat
Journal:  Rev Endocr Metab Disord       Date:  2008-03       Impact factor: 6.514

Review 9.  Chemoprevention of colorectal cancer by targeting obesity-related metabolic abnormalities.

Authors:  Yohei Shirakami; Masahito Shimizu; Masaya Kubota; Hiroshi Araki; Takuji Tanaka; Hisataka Moriwaki; Mitsuru Seishima
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

Review 10.  Crossroad between Obesity and Gastrointestinal Cancers: A Review of Molecular Mechanisms and Interventions.

Authors:  Mitra Moodi; Tahmineh Tavakoli; Zoya Tahergorabi
Journal:  Int J Prev Med       Date:  2021-02-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.